FDA approves first two-drug complete regimen for HIV-infected patients who have never received antiretroviral treatment - FDA Press Releases

FDA today approved Dovato (dolutegravir and lamivudine), as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. This is the first FDA-approved two-drug, fixed-dose, complete regimen for HIV-infected adults who have never received antiretroviral treatment for HIV.

from Food and Drug Administration--Press Releases http://bit.ly/2ImsfXE
via IFTTT